Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Critical Care Clinics|June 1, 2020
Overview of Management of Intermediate- and High-Risk Pulmonary EmbolismVictor F Tapson, Aaron S WeinbergDermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|July 31, 2007
Metastatic cutaneous squamous cell carcinoma: an updateAaron S Weinberg, Christina A Ogle, Elisabeth K ShimJournal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|October 26, 2023
Guideline Compliance and Indications for Inferior Vena Cava Filter Placement at a Quaternary Care Medical CenterJune Choe, Richard Liang, Aaron S Weinberg, et al.Journal of Intensive Care Medicine|October 24, 2018
Portable Ventilation/Perfusion Scanning is Useful for Evaluating Clinically Significant Pulmonary Embolism in the ICU Despite Abnormal Chest RadiographyAaron S Weinberg, William Chang, Grace Ih, et al.Journal of Intensive Care Medicine|January 30, 2020
Use of the Bedside-Placed Angel Catheter IVC Filter for Venous Thromboembolic Disease in Critically Ill Medical PatientsYuri Matusov, Aaron S Weinberg, Richard Liang, et al.Journal of Medical Internet Research|November 23, 2020
Development and External Validation of a Machine Learning Tool to Rule Out COVID-19 Among Adults in the Emergency Department Using Routine Blood Tests: A Large, Multicenter, Real-World StudyTimothy B Plante, Aaron M Blau, Adrian N Berg, et al.Vaccine|July 27, 2025
A phase 3 randomized, double-blind clinical study to evaluate the safety and immunogenicity of V116 when administered concomitantly with influenza vaccine in adults 50 years of age or olderTosin Omole, Aaron S Weinberg, Masoud Azizad, et al.Vaccines|February 26, 2025
Safety, Tolerability, and Immunogenicity of the Pneumococcal Vaccines PPSV23 or PCV15 Co-Administered with a Booster Dose of mRNA-1273 SARS-CoV-2 Vaccine in Healthy Adults ≥50 Years of AgeTosin Omole, Enrique Pelayo, Aaron S Weinberg, et al.Vaccines|October 28, 2025
Correction: Omole et al. Safety, Tolerability, and Immunogenicity of the Pneumococcal Vaccines PPSV23 or PCV15 Co-Administered with a Booster Dose of mRNA-1273 SARS-CoV-2 Vaccine in Healthy Adults ≥50 Years of Age. Vaccines 2025, 13, 192Tosin Omole, Enrique Pelayo, Aaron S Weinberg, et al.Chest|August 31, 2020
Diagnosis and Treatment of Pulmonary Embolism During the Coronavirus Disease 2019 Pandemic: A Position Paper From the National PERT ConsortiumRachel P Rosovsky, Charles Grodzin, Richard Channick, et al.Pageof 2